These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8105056)

  • 1. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
    Wanwimolruk S; Nyika S; Kepple M; Ferry DG; Clark CR
    J Pharm Pharmacol; 1993 Jul; 45(7):618-21. PubMed ID: 8105056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.
    Groen K; Horan MA; Roberts NA; Gulati RS; Miljkovic B; Jansen EJ; Paramsothy V; Breimer DD; van Bezooijen CF
    Clin Pharmacokinet; 1993 Aug; 25(2):136-44. PubMed ID: 8403737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of leukotriene C4 on theophylline disposition in guinea pigs.
    Tanigawara Y; Yano I; Yasuhara M; Hori R
    Am Rev Respir Dis; 1992 Sep; 146(3):616-20. PubMed ID: 1519837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nifedipine on antipyrine and theophylline disposition.
    Adebayo GI; Mabadeje AF
    Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.
    Zhang H; Wong CW; Coville PF; Wanwimolruk S
    Drug Metabol Drug Interact; 2000; 17(1-4):351-63. PubMed ID: 11201303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fluconazole on antipyrine kinetics in rats.
    Ramzan I; Chan M
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):273-6. PubMed ID: 8149946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.
    Badiola N; Al-Angary AN; Halbert GW
    J Pharm Pharmacol; 1992 Apr; 44(4):366-8. PubMed ID: 1355554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.
    Salako LA; Sowunmi A
    Eur J Clin Pharmacol; 1992; 42(2):171-4. PubMed ID: 1618248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K; Muszczynski Z; Suszycka J
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.
    Webster LK; Ellis AG; Bishop JF
    Cancer Chemother Pharmacol; 1993; 31(4):319-23. PubMed ID: 8422697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.
    Hasegawa T; Nadai M; Haghgoo S; Yamaki K; Takagi K; Nabeshima T
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2138-40. PubMed ID: 8540732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Kappas A; Anderson KE; Conney AH; Alvares AP
    Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified approaches to the determination of antipyrine pharmacokinetic parameters.
    Scavone JM; Greenblatt DJ; Blyden GT; Harmatz JS; Graziano PJ
    Br J Clin Pharmacol; 1988 Jun; 25(6):695-9. PubMed ID: 3203041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination.
    Dieterich HA; Messer W; Jaehnchen E
    Arzneimittelforschung; 1984; 34(4):520-2. PubMed ID: 6540112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.